Mar 2, 2022 7:30 am EST MindMed Announces Publication of Study Comparing the Acute Effects of Lysergic Acid Diethylamide and Psilocybin in Healthy Subjects
Jan 25, 2022 7:30 am EST FDA Clears MindMed IND for MM-120 in Treatment of Generalized Anxiety Disorder
Jan 18, 2022 7:30 am EST MindMed Enrolls First Participant in a Study of its Session Monitoring System
Dec 30, 2021 7:30 am EST MindMed to Participate at the LifeSci Partners 11th Annual Corporate Access Event
Dec 21, 2021 7:30 am EST MindMed Provides Status Update on IND for Phase 2b Trial of LSD for the Treatment of Generalized Anxiety Disorder